Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients

Drug and Alcohol Dependence

Volumn 89, Issue 1, 2007, Pages 60-65

  Rinck, Daniela ^a   Frieling, Helge ^a   Freitag, Anne ^a   Hillemacher, Thomas ^a   Bayerlein, Kristina ^a   Kornhuber, Johannes ^a   Bleich, Stefan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Alcohol dependence; Biomarker; CDT; GGT; Homocysteine; MCV

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE;

ADULT; AGED; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; CLINICAL PRACTICE; CONTROL GROUP; CONTROLLED STUDY; DRINKING; FEMALE; GENDER; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALCOHOLISM; BIOLOGICAL MARKERS; ERYTHROCYTE INDICES; FEMALE; FOLIC ACID; GAMMA-GLUTAMYLTRANSFERASE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TRANSFERRIN;

EID: 34247154303     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.11.022     Document Type: Article

References (36)

1. Alte D., Luedemann J., Rose H.J., and John U. Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP). Alcohol Clin. Exp. Res. 28 (2004) 931-940
2. Anton R.F., Dominick C., Bigelow M., and Westby C. Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase. Clin. Chem. 47 (2001) 1769-1775
3. Anton R.F., Lieber C., and Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin. Exp. Res. 26 (2002) 1215-1222
4. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin. Chem. 47 (2001) 13-27
5. Bell H., Tallaksen C.M., Try K., and Haug E. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin. Exp. Res. 18 (1994) 1103-1108
6. Bisson J.I., and Milford-Ward A. A comparison of carbohydrate deficient transferrin with other markers of alcohol misuse in male soldiers under the age of thirty. Alcohol Alcohol. 29 (1994) 315-321
7. Bleich S., Degner D., Javaheripour K., Kurth C., and Kornhuber J. Homocysteine and alcoholism. J. Neural Transm. Suppl. (2000) 187-196
8. Bleich S., Degner D., Wiltfang J., Maler J.M., Niedmann P., Cohrs S., Mangholz A., Porzig J., Sprung R., Ruther E., and Kornhuber J. Elevated homocysteine levels in alcohol withdrawal. Alcohol Alcohol. 35 (2000) 351-354
9. Bleich S., Degner D., Sperling W., Bönsch D., Thürauf N., and Kornhuber J. Homocysteine as a neurotoxin in chronic alcoholism. Prog. Neuropychopharmacol. Biol. Psychiatry 28 (2004) 453-464
10. Bleich S., Carl M., Bayerlein K., Reulbach U., Biermann T., Hillemacher T., Bönsch D., and Kornhuber J. Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS). Alcohol Clin. Exp. Res. 29 (2005) 334-336
11. Conigrave K.M., Degenhardt L.J., Whitfield J.B., Saunders J.B., Helander A., and Tabakoff B. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin. Exp. Res. 26 (2002) 332-339
12. Conigrave K.M., Davies P., Haber P., and Whitfield J.B. Traditional markers of excessive alcohol use. Addiction 98 (2003) 31-43
13. de la Vega M.J., Santolaria F., Gonzalez-Reimers E., Aleman M.R., Milena A., Martinez-Riera A., and Gonzalez-Garcia C. High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol 25 (2001) 59-67
14. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), 2004. Riskanter, schädlicher und abhängiger Alkoholkonsum: Screening, Diagnostik, Kurzintervention. Sucht. 50, 102-112.
15. Dlugosch G.E., and Krieger W. Fragebogen zur Erfassung des Gesundheitsverhaltens (FEG). 2nd ed. (2002), Swets Test Services GmbH, Frankfurt am Main
16. Gomez A., Conde A., Aguiar J.A., Santana J.M., Jorrin A., and Betancor P. Diagnostic usefulness of carbohydrate-deficient transferrin for detecting alcohol-related problems in hospitalized patients. Alcohol Alcohol. 36 (2001) 266-270
17. Heinemann A., Sterneck M., Kuhlencordt R., Rogiers X., Schulz K.H., Queen B., Wischhusen F., and Puschel K. Carbohydrate-deficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation. Alcohol Clin. Exp. Res. 22 (1998) 1806-1812
18. Helander A., Carlsson A.V., and Borg S. Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol. 31 (1996) 101-107
19. Helander A., Eriksson G., Stibler H., and Jeppsson J.O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin. Chem. 47 (2001) 1225-1233
20. Hock B., Schwarz M., Domke I., Grunert V.P., Wuertemberger M., Schiemann U., Horster S., Limmer C., Stecker G., and Soyka M. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100 (2005) 1477-1486
21. Hultberg B., Berglund M., Andersson A., and Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin. Exp. Res. 17 (1993) 687-689
22. John U., Rumpf H.J., and Hapke U. Estimating prevalence of alcohol abuse and dependence in one general hospital: an approach to reduce sample selection bias. Alcohol Alcohol. 34 (1999) 786-794
23. Johnston D.E. Special considerations in interpreting liver function tests. Am. Fam. Physician 59 (1999) 2223-2230
24. Koch H., Meerkerk G.J., Zaat J.O., Ham M.F., Scholten R.J., and Assendelft W.J. Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol. 39 (2004) 75-85
25. Kornhuber J., Kornhuber H.H., Backhaus B., Kornhuber A., Kaiserauer C., and Wanner W. The normal values of gamma-glutamyltransferase are falsely defined up to now: on the diagnosis of hypertension, obesity and diabetes with reference to "normal" consumption of alcohol. Versicherungsmedizin 41 (1989) 78-81
26. Lesch O.M., and Walter H. Subtypes of alcoholism and their role in therapy. Alcohol Alcohol. 31 Suppl. 1 (1996) 63-67
27. Maruyama S., Hirayama C., Yamamoto S., Koda M., Udagawa A., Kadowaki Y., Inoue M., Sagayama A., and Umeki K. Red blood cell status in alcoholic and non-alcoholic liver disease. J. Lab. Clin. Med. 138 (2001) 332-337
28. Miller P.M., and Anton R.F. Biochemical alcohol screening in primary health care. Addict. Behav. 29 (2004) 1427-1437
29. Mowe M., and Bohmer T. Increased levels of alcohol markers (gamma GT, MCV, ASAT, ALAT) in older patients are not related to high alcohol intake. J. Am. Geriatr. Soc. 44 (1996) 1136-1137
30. Neumann T., and Spies C. Use of biomarkers for alcohol use disorders in clinical practice. Addiction 98 Suppl. 2 (2003) 81-91
31. Pratt D.S., and Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 342 (2000) 1266-1271
32. Reynaud M., Schellenberg F., Loisequx-Meunier M.N., Schwan R., Maradeix B., Planche F., and Gillet C. Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV). Alcohol Clin. Exp. Res. 24 (2000) 1414-1419
33. Sillanaukee P., Strid N., Jousilahti P., Vartiainen E., Poikolainen K., Nikkari S., Allen J.P., and Alho H. Association of self-reported diseases and health care use with commonly used laboratory markers for alcohol consumption. Alcohol Alcohol. 36 (2001) 339-345
34. Wetterling T., Kanitz R.D., Rumpf H.J., Hapke U., and Fischer D. Comparison of cage and mast with the alcohol markers CDT, gamma-GT, ALAT, ASAT and MCV. Alcohol Alcohol. 33 (1998) 424-430
35. Whitfield J.B., Zhu G., Heath A.C., Powell And L.W., and Martin N.G. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin. Exp. Res. 25 (2001) 1037-1045
36. Wuyts B., Delanghe J.R., Kasvosve I., Gordeuk V.R., Gangaidzo I.T., and Gomo Z.A. Carbohydrate-deficient transferrin and chronic alcohol ingestion in subjects with transferrin CD-variants. Clin. Chem. Lab. Med. 39 (2001) 937-943